Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus

N Engl J Med. 2024 Sep 5;391(9):864-866. doi: 10.1056/NEJMc2407150.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Bispecific / administration & dosage
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • B-Cell Maturation Antigen* / antagonists & inhibitors
  • B-Cell Maturation Antigen* / immunology
  • Drug Resistance
  • Female
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Injections, Subcutaneous
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Lupus Erythematosus, Systemic* / immunology
  • Remission Induction* / methods

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • B-Cell Maturation Antigen
  • Immunosuppressive Agents